Skip to main content
Fig. 4 | BMC Microbiology

Fig. 4

From: Characterization of novel bacteriophage PSKP16 and its therapeutic potential against β-lactamase and biofilm producer strain of K2-Hypervirulent Klebsiella pneumoniae pneumonia infection in mice model

Fig. 4

A Results of the effect of phage PSKP16 on biofilm formation of BhvKp strain in different MOI. B degradation assay of PSKP16 mediated BhvKp strain preformed biofilm in different MOI, at 24 h and 48 h old biofilm of BhvKp strain. Biofilm formation and performed biofilms grown on the microtiter plate wells for 24 or 48 h, were inoculated with 10- 10.8 pfu of phage PSKP16. Percentage of biofilm was scored relative to untreated control samples (100%) and represented on the Y-axes. Data represent mean ± SD from the triplicate experiments. CN + KP (Control + K. pneumoniae (Bhvkp)), CN + PA (Control + Pseudomonas aeruginosa ATCC 27853)

Back to article page